In addition, RILPL2 could promote tumor progression via the TUBB3/PTEN pathway in breast cancer, and there were reported associations between RILPL2 and the infiltration patterns of multiple immune cell types in endometrial carcinoma [7, 8]. This evidence concerns the gene RILPL2 and endometrial carcinoma.